Neurofibromatosis and Childhood Leukaemia
Author Information
Author(s): A Zvulunov, A Metzker
Primary Institution: Soroka Medical Center, Beer-Sheva, Israel; Shneider's Children's Medical Center, Petah-Tiqva, Israel
Hypothesis
Children with neurofibromatosis type 1 (NF-1) and cutaneous juvenile xanthogranuloma (JXG) may have a greater risk of juvenile chronic myelogenous leukaemia (JCML).
Conclusion
The study suggests that the risk of JCML in children with NF-1 and JXG is significantly higher than in those without JXG.
Supporting Evidence
- The relative risk for JCML in children with NF-1 and JXG is estimated to be 20- to 32-fold greater than in those without JXG.
- The frequency of JCML among children with NF-1 and JXG is between 1/52 and 1/84.
- This frequency is 1700- to 5500-fold higher than in the general population.
Takeaway
Kids with a condition called neurofibromatosis and certain skin bumps might get a type of blood cancer much more often than other kids.
Methodology
Data from published cases of NF-1, JXG, and JCML were analyzed to estimate relative risks.
Limitations
The inclusion of a patient with JXG may have skewed the risk calculations for those without JXG.
Participant Demographics
Children with neurofibromatosis type 1 and juvenile xanthogranuloma.
Want to read the original?
Access the complete publication on the publisher's website